OPKO Corp (OPK): Earnings per share for the last twelve months

Corporate emblem and logo of OPKO Health (OPK)

The 12-month net income per share snapshot on the GURU.Markets terminal chart demonstrates the financial stability of OPKO Health, Inc. (OPK), where the -0.20 mark indicates the current state. Laboratory automation via AI and robotics minimizes routine tasks, although sample collection remains the responsibility of personnel. Standard check-ups and patents serve as a steady cash generator, while the development of the R&D pipeline and veterinary products ensures steady innovative growth.

OPK OPKO Health, Inc. Net earnings per one share for the last twelve months (07/04/2022 - 11/15/2026)

Summary analytical data breakdowns for OPKO Health Corp. (OPK)

- stock price and consensus target price:
- stock exchange capitalization data:
Basic company analysis:OPKO Health - OPK
Mass-produced product of OPKO Corp

OPKO Health, Inc. (OPK) is currently undergoing a phase of restructuring and asset portfolio optimization to overcome a downturn in its laboratory segment. By analyzing the trailing 12-month EPS, investors can separate the real profitability trend from market noise, assessing net income per share to identify business pivot points and avoid overpaying for decelerating growth rates.

Competing companies

agilent.com - Net earnings per share (EPS TTM)|Net earnings per share for the last four quarters Quest Diagnostics Inc. DGX|ILMN: Net earnings per share (EPS TTM)|EXAS - Net earnings per share for the last four quarters|Earnings per share for the last twelve months revvity.com|Earnings per share for the last twelve months BIO|Net earnings per share (EPS TTM) NNNN|SHC - Net earnings per one share for the last twelve months|Quidel Corporation - Net earnings per share for the last 12 months|Net earnings per share (EPS TTM) CareDx, Inc CDNA|MRVI - Earnings per share for the last twelve months|FLGT: Earnings per share for the last twelve months|LAB: Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Cytek Biosciences Inc (CTKB)|Net earnings per share for the last 12 months OSUR|Earnings per share for the last 12 months XGN (Exagen)|Net earnings per share (EPS TTM) MDXH|LUCD (Lucid Diagnostics Inc.) - Earnings per share for the trailing year|Net earnings per share (EPS TTM) PRE (Prenetics Global)|Earnings per share for the last four quarters IMDX (imdxinc.com)|TRIB: Net earnings per share for the last 12 months|Net earnings per one share for the last twelve months ProPhase Labs, Inc.|AIMD: Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months codiagnostics.com (CODX)|Net earnings per share for the last 12 months HSCS|BMRA: Earnings per share for the trailing year|Net earnings per share (EPS TTM) CDIO|Net earnings per share for the last four quarters Onconetix Corporation|Net earnings per share (EPS TTM) VRAX (Virax Biolabs Group)|Net earnings per share for the trailing year bluejaydx.com|AWH: Net earnings per share for the last 12 months|Net earnings per share for the last four quarters Accelerate Diagnostics, Inc. AXDX|CNTG (CENTOGENE) - Net earnings per share for the last 12 months|Earnings per share for the last 12 months ENZ|FRES: Net earnings per share for the last four quarters|Earnings per share for the last twelve months GENE|Net earnings per share for the last 12 months ME (23andMe Holding Co)|PMD - Net earnings per one share for the last twelve months